| Nov 7 |
Q3 2024 Trevi Therapeutics Inc Earnings Call
|
| Nov 7 |
Trevi Therapeutics Inc (TRVI) Q3 2024 Earnings Call Highlights: Navigating Increased Losses and ...
|
| Nov 7 |
Trevi Therapeutics, Inc. (TRVI) Q3 2024 Earnings Call Transcript
|
| Nov 6 |
Trevi Therapeutics EPS of -$0.13 misses by $0.02
|
| Nov 6 |
Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
|
| Oct 30 |
Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024
|
| Oct 23 |
Rosalind Advisors, Inc. Reduces Stake in Trevi Therapeutics Inc.
|
| Oct 21 |
Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough
|
| Oct 15 |
Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences
|
| Oct 9 |
Trevi Therapeutics Inc (TRVI) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges ...
|
